Animal studies have indicated a decrease in the expression of Sfrp5 in obese models, while Sfrp5 deficiency causes insulin resistance, glucose intolerance, and hepatosteatosis [8,13]. The gene discussed is SFRP5; the disease is Insulin resistance.